SynPhNe, a digital neurological therapeutics company, earlier announced that it had “adopted telehealth initiatives to provide virtual therapy/online sessions to their patients” amidst the COVID-19 pandemic. This is vital for continuity of care to “patients suffering from Neuromuscular disorders such as stroke, traumatic brain injuries (TBI), Parkinson’s disease and learning disabilities (LD)” who, due to the pandemic, were left “in a precarious condition because of a sudden loss of access to therapy.”
To expand on these points, Kerean Watts, editor of Health Issues India, interviewed Abhijeet Pandit – director and chief executive officer, SynPhNe India Pvt Ltd, VP Global Network Dev. and Marketing. Watch the interview here.
Abhijeet Pandit is currently leading the India operations for SynPhNe (an abbreviation for Synergistic Physio-Neuro platform). He is also directly responsible for developing SynPhNe’s network, and to strategise and implement the Marketing activities to build the SynPhNe brand globally.
SynPhNe is the world’s first connected, wearable solution that trains brain and muscle as one system. It helps improve functional independence to persons with disability after stroke or injury, or due to ageing.
A Mechanical Engineer and MBA, he has spent the last 26 years of his career at various country leadership roles in India, Middle-East and Europe. His quintessential marketing skills have played a key role in readying and implementing SynPhNe’s market strategy in India and internationally.
Before joining SynPhNe, he has worked with acclaimed Indian and International automobiles companies such as TATA Motors, Nissan Motor Company and Al-Futtaim Honda.
After spending eighteen years abroad, in the M.E and Europe, he returned to India in 2013 as the Group CEO of Autohangar India Private Limited, managing retail operations of International brands namely Mercedes Benz, AMG, Honda, Lamborghini and Indian Motorcycles. Abhijeet has been instrumental in driving business development and expansion across multiple countries including India, the Sultanate of Oman, the United Arab Emirates, Thailand, Indonesia and some markets in Europe. With a proven track record and international expertise, he brings high-level marketing and management proficiencies to SynPhNe.
Born in India, he is passionate about tennis and fitness and is an alumnus of S.P. Jain Institute of Management and Research, Mumbai.
About SynPhNe Pte.
Founded in 2014 in Singapore, SynPhNe has its corporate headquarters in Singapore and two subsidiaries, one in Mumbai, India and second in New Jersey, US. SynPhNe is the world’s first medical device that trains brain and muscle as one system helping patients to restore their functional capabilities and cognition post stroke. It aims to make the patient independent again.
The company’s mission is to develop technologies which restore the first line of treatment and cure for chronic disability and disease.
For more information, visit: http://www.synphne.in/